Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer
Prostate Cancer
About this trial
This is an interventional diagnostic trial for Prostate Cancer focused on measuring recurrent prostate cancer, stage I prostate cancer, stage IIB prostate cancer, stage IIA prostate cancer, stage III prostate cancer, stage IV prostate cancer
Eligibility Criteria
DISEASE CHARACTERISTICS: Histologically confirmed prostate cancer Completed or planned definitive radiotherapy PATIENT CHARACTERISTICS: Age Adult Performance status Not specified Life expectancy Not specified Hematopoietic Not specified Hepatic Not specified Renal Not specified PRIOR CONCURRENT THERAPY: Biologic therapy Concurrent immunotherapy allowed Chemotherapy Concurrent chemotherapy allowed Endocrine therapy Concurrent hormonal therapy allowed Radiotherapy See Disease Characteristics Concurrent palliative radiotherapy allowed Surgery No prior prostatectomy, including radical prostatectomy No concurrent radical prostatectomy
Sites / Locations
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
- NCI - Center for Cancer Research